Agile Therapeutics Inc (AGRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AGRX Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Agile Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent2.85
Cash & Short-term Investments2.00
Accounts receivable4.55
Inventories5.79
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.25
Total Current Assets14.44
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent0.49
Operating Lease Right Of Use Asset0.26
Total Assets14.96
Liabilities
Accounts Payable, Current AC16.54
Accrued Liabilities, Current AC9.40
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.29
Total Current Liabilities26.23
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE10.65
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.29
Operating Lease Liability Noncurrent0.00
Total Liabilities36.88
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock411.84
Retained Earnings / Accumulated Deficit-433.76
Other Equity0.00
Common Stockholder's Equity-21.91
Total Stockholder's Equity-21.91
Liabilities & Stockholder's Equity14.96
4 historic quarters locked

Sign in to unlock the full Agile Therapeutics Inc balance sheet history.

About Agile Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-24-011904

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.